3rd Jul 2013 18:04
Notification of Transactions of Directors, Persons Discharging
Managerial Responsibility or Connected Persons
The Administrators of the GlaxoSmithKline 2009 Deferred Annual Bonus Plan (the Plan) notified the Company and the under-mentioned persons on 2 July 2013 of an increase in their notional interests in Ordinary Shares and American Depositary Shares (ADSs). In respect of the 2011 and 2012 Plan awards, this reflects a reconciliation of notional dividends following a change in Plan administration such that the originally intended number of notional dividends will accrue over the course of the relevant vesting period. The notional dividends were re-invested on 28 June 2013 at an average price of 1404.56 pence per Ordinary Share and $44.5889 per ADS in respect of 2011 Plan awards and at an average price of 1448.10 pence per Ordinary Share and $45.9620 per ADS in respect of 2012 Plan awards.
Sir Andrew Witty | Acquisition of 1,516 Ordinary Shares under the personal contribution element of the Plan. |
Acquisition of 1,516 Ordinary Shares under the matching element of the Plan (Company contribution). | |
Mr S Dingemans | Acquisition of 568 Ordinary Shares under the personal contribution element of the Plan. |
Acquisition of 568 Ordinary Shares under the matching element of the Plan (Company contribution). | |
Dr M M Slaoui
| Acquisition of 695 ADSs under the personal contribution element of the Plan. |
Acquisition of 695 ADSs under the matching element of the Plan (Company contribution). | |
Mr S M Bicknell | Acquisition of 312 Ordinary Shares under the personal contribution element of the Plan. |
Acquisition of 312 Ordinary Shares under the matching element of the Plan (Company contribution). | |
Mrs D P Connelly | Acquisition of 172 ADSs under the personal contribution element of the Plan. |
Acquisition of 172 ADSs under the matching element of the Plan (Company contribution). | |
Mr W C Louv | Acquisition of 94 ADSs under the personal contribution element of the Plan. |
Acquisition of 94 ADSs under the matching element of the Plan (Company contribution). | |
Mr D S Redfern | Acquisition of 374 Ordinary Shares under the personal contribution element of the Plan. |
Acquisition of 374 Ordinary Shares under the matching element of the Plan (Company contribution). | |
Ms C Thomas | Acquisition of 326 Ordinary Shares under the personal contribution element of the Plan. |
Acquisition of 326 Ordinary Shares under the matching element of the Plan (Company contribution). | |
Mr D E Troy | Acquisition of 356 ADSs under the personal contribution element of the Plan. |
Acquisition of 356 ADSs under the matching element of the Plan (Company contribution). | |
Dr P J T Vallance | Acquisition of 675 Ordinary Shares under the personal contribution element of the Plan. |
Acquisition of 675 Ordinary Shares under the matching element of the Plan (Company contribution). | |
Ms E Walmsley | Acquisition of 206 Ordinary Shares under the personal contribution element of the Plan. |
Acquisition of 206 Ordinary Shares under the matching element of the Plan (Company contribution). |
The notional dividends accrued will be paid out in proportion to the percentage of the participant's deferred annual bonus holdings that will vest following the end of the relevant three year measurement period.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
3 July 2013
Related Shares:
Glaxosmithkline